# Stephen MacMahon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stephen-macmahon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,578 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 98 |
| i10-index | 242 |
| Last Known Institution | UNSW Sydney |
| OpenAlex ID | https://openalex.org/A5026262569 |
| ORCID iD | https://orcid.org/0000-0003-2064-7699 |
| Works | 530 |

## Researcher papers

- [Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/intensive-blood-glucose-control-and-vascular-outcomes-in-patients-with-type-2/)
- [Interpretation of the evidence for the efficacy and safety of statin therapy](https://scholariq.org/papers/interpretation-of-the-evidence-for-the-efficacy-and-safety-of-statin-therapy/)
- [Severe Hypoglycemia and Risks of Vascular Events and Death](https://scholariq.org/papers/severe-hypoglycemia-and-risks-of-vascular-events-and-death/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis](https://scholariq.org/papers/effects-of-intensive-blood-pressure-lowering-on-cardiovascular-and-renal-2/)
- [Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes](https://scholariq.org/papers/albuminuria-and-kidney-function-independently-predict-cardiovascular-and-renal/)
- [Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/effects-of-intensive-blood-pressure-lowering-on-cardiovascular-and-renal/)
- [HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment](https://scholariq.org/papers/hps2-thrive-randomized-placebo-controlled-trial-in-25-673-high-risk-patients-of/)
- [Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes](https://scholariq.org/papers/follow-up-of-blood-pressure-lowering-and-glucose-control-in-type-2-diabetes/)
- [Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis](https://scholariq.org/papers/age-stratified-and-blood-pressure-stratified-effects-of-blood-pressure-lowering/)
- [Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History](https://scholariq.org/papers/effects-of-a-perindopril-based-blood-pressure-lowering-regimen-on-the-risk-of/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Global Public Health Policies and Epidemiology](https://scholariq.org/topics/global-public-health-policies-and-epidemiology/)

## Researcher university

- [UNSW Sydney](https://scholariq.org/institutions/unsw-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.